Welcome: Guest

log in

North American Mobile CRM Markets - Investment Analysis

Publication Date September 2008
Publisher Frost & Sullivan
Product Type Report
Pages
ISBN Number not applicable
Product Code FRS00225
Buy this product or for assistance call +44 20 7060 7474

Summary

This research service from the Mobile CRM business and financial services group highlights growth sectors of notable interest and also provides a comprehensive financial analysis of the leading Mobile CRM firms. This study presents a broad outline of the current Mobile CRM industry, highlighting major market and financial trends with an emphasis on seven growth segments, namely, Mobile Field Sales Automation (MFSA) and Mobile Field Service Management (MFSM).

Content

  • Executive summary
    • Executive summary
      • Executive summary
  • Introduction and methodology
    • Introduction and methodology
      • Introduction
      • Methodology
  • Industry fundamentals
    • Industry fundamentals
      • Industry overview
      • Mobile crm architecture
      • Msfa
      • Mfsm
      • Industry dynamics
      • Supporting segments
    • Investment analysis
      • Investment themes
      • Sector score card
      • Growth monitor
  • Financial benchmarking analysis
    • Frost & sullivan mcrm universe
      • Industry classification
    • Industry profitability analysis
      • Operating profit margin
      • Selling general and administrative expenses to sales
      • Research and development expenses to sales
      • Net profit margin
      • Comparison of margins and cosg
      • Price to innovation
      • Revenue per employee
    • Balance sheet analysis
      • Current ratio
      • Fixed cost analysis
      • Goodwill analysis
    • Valuation
      • Historical/current mergers & acquisition and valuation
      • Venture capital score card
      • Venture opportunity score card
Delivery Details

PDF:Delivered by email within 12 to 24 hours of placing the order (Mon-Fri

Industry Events

Oncology Market & Patient Access

14 Dec 09 to 16 Dec 09
Prague, Czech Republic
view summary >>

Orphan & Ultra Orphan Drugs

13 Jan 10 to 14 Jan 10
Brussels, Belgium
view summary >>